ST&D offers wireless vital signs platform
ST&D is an internationally recognised and leading innovator in targeted vital signs monitoring. It has developed a solution to the issue of remote monitoring with its flexible wireless vital signs platform that can be customised to provide various monitoring products.
The elements provided include a miniaturised short-range body-worn wireless monitor with long battery life, on-board intelligence to monitor for and trigger on medical events such as arrhythmias. Also available is a matching belt-worn device using cellular links to send data immediately to the clinician. It has non-irritant, easy to apply patch electrodes for high-quality collection of vital signs.
Examples of products developed from this platform include instantaneous Holter monitors, in-hospital multiple vital signs monitors and pulse-wave velocity screeners.
This article was published on 12/27/2006
Search
Service
Company News
Accu-Chek® Combo – put effective diabetes management into action
At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.
Products redesigned to help patients simplify life with diabetes
Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
Carestream: technical infrastructure for EU funded R-bay project
Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.